UPH Stock Overview

Operates and manages outpatient physical therapy clinics. More details

UPH fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	2/6
Past Performance	4/6
Financial Health	5/6
Dividends	4/6

Rewards

Trading at 58% below our estimate of its fair value

Earnings are forecast to grow 13.71% per year

Earnings grew by 86.3% over the past year

Analysts in good agreement that stock price will rise by 33%

Risk Analysis

Unstable dividend track record

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

U.S. Physical Therapy, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for U.S. Physical Therapy
Historical stock prices
Current Share Price	US$70.50
52 Week High	US$97.50
52 Week Low	US$57.50
Beta	1.44
1 Month Change	16.53%
3 Month Change	-15.06%
1 Year Change	-27.32%
3 Year Change	-29.50%
5 Year Change	2.17%
Change since IPO	443.98%

Recent updates

Shareholder Returns

	UPH	DE Healthcare	DE Market
7D	6.0%	1.0%	0.8%
1Y	-27.3%	40.5%	15.0%

Return vs Industry: UPH underperformed the German Healthcare industry which returned 39.6% over the past year.

Return vs Market: UPH underperformed the German Market which returned 14.4% over the past year.

Price Volatility

Is UPH's price volatile compared to industry and market?
UPH volatility
UPH Average Weekly Movement	5.8%
Healthcare Industry Average Movement	6.5%
Market Average Movement	6.5%
10% most volatile stocks in DE Market	12.8%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: UPH has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: UPH's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1990	5,531	Chris Reading	www.usph.com

U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

U.S. Physical Therapy, Inc. Fundamentals Summary

How do U.S. Physical Therapy's earnings and revenue compare to its market cap?
UPH fundamental statistics
Market cap	€1.08b
Earnings (TTM)	€29.19m
Revenue (TTM)	€615.96m

36.9x

P/E Ratio

1.7x

P/S Ratio

Is UPH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UPH income statement (TTM)
Revenue	US$692.33m
Cost of Revenue	US$541.76m
Gross Profit	US$150.56m
Other Expenses	US$117.75m
Earnings	US$32.81m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	2.16
Gross Margin	21.75%
Net Profit Margin	4.74%
Debt/Equity Ratio	21.9%

How did UPH perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

81%

Payout Ratio

Does UPH pay a reliable dividends?

See UPH dividend history and benchmarks

When do you need to buy UPH by to receive an upcoming dividend?
U.S. Physical Therapy dividend dates
Ex Dividend Date	May 23 2025
Dividend Pay Date	Jun 13 2025
Days until Ex dividend	3 days
Days until Dividend pay date	24 days

Does UPH pay a reliable dividends?

See UPH dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 11:50
End of Day Share Price	2025/05/19 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

U.S. Physical Therapy, Inc. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Michael Petusky	Barrington Research Associates, Inc.
Joanna Sylvia Gajuk	BofA Global Research
null null	Burkenroad Reports

UPH Stock Overview

Rewards

Risk Analysis

U.S. Physical Therapy, Inc. Competitors

RHÖN-KLINIKUM

M1 Kliniken

MEDICLIN

LIMES Schlosskliniken

Price History & Performance

Recent News & Updates

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on June 13, 2025

U.S. Physical Therapy, Inc. to Report Q1, 2025 Results on May 07, 2025

U.S. Physical Therapy, Inc., Annual General Meeting, May 20, 2025

U.S. Physical Therapy, Inc. Raises Quarterly Dividend and Declares Quarterly Dividend for the First Quarter of 2025, Payable on April 11, 2025

U.S. Physical Therapy, Inc. to Report Q4, 2024 Results on Feb 27, 2025

President & COO recently sold €179k worth of stock

Recent updates

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on June 13, 2025

U.S. Physical Therapy, Inc. to Report Q1, 2025 Results on May 07, 2025

U.S. Physical Therapy, Inc., Annual General Meeting, May 20, 2025

U.S. Physical Therapy, Inc. Raises Quarterly Dividend and Declares Quarterly Dividend for the First Quarter of 2025, Payable on April 11, 2025

U.S. Physical Therapy, Inc. to Report Q4, 2024 Results on Feb 27, 2025

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Now 21% undervalued after recent price drop

Chairman & CEO recently sold €196k worth of stock

Chief Operating Officer - East recently sold €242k worth of stock

First quarter dividend of US$0.44 announced

First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

Now 21% undervalued

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Chief Operating Officer - West recently sold €413k worth of stock

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022)

Independent Director recently sold €439k worth of stock

Executive VP recently sold €87k worth of stock

Upcoming dividend of US$0.43 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021)

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently sold €573k worth of stock

President recently sold €858k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

Insufficient new directors

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold €162k worth of stock

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021)

U.S. Physical Therapy, Inc. Provides Operating Guidance for 2022

U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million.

Director recently bought €78k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million.

Independent Director recently bought €82k worth of stock

Independent Director recently bought €54k worth of stock

Second quarter 2022 earnings released: EPS: US$0.86 (vs US$0.82 in 2Q 2021)